causalityObservations - HL7 Terminology (THO) v6.0.2

HL7 Terminology (THO)
6.0.2 - Continuous Process Integration (ci build) International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 6.0.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

CodeSystem: causalityObservations

Official URL: http://terminology.hl7.org/CodeSystem/v2-0252		Version: 2.0.0
Active as of 2019-12-01	Responsible: Health Level Seven International	Computable Name: CausalityObservations
Other Identifiers: OID:2.16.840.1.113883.18.147
Copyright/Legal: This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html

HL7-defined code system of concepts used to record event observations regarding what may have caused a product related event. Used in HL7 Version 2.x messaging in the PCR segment.

Underlying Master Code System for V2 table 0252 (Causality Observations)

This Code system is referenced in the content logical definition of the following value sets:

Hl7VSCausalityObservations

Generated Narrative: CodeSystem v2-0252

Properties

This code system defines the following properties for its concepts

Name

Code

URI

Type

Description

status

http://terminology.hl7.org/CodeSystem/utg-concept-properties#status

code

Status of the concept

deprecated

http://terminology.hl7.org/CodeSystem/utg-concept-properties#v2-table-deprecated

code

Version of HL7 in which the code was deprecated

Concepts

This case-sensitive code system http://terminology.hl7.org/CodeSystem/v2-0252 defines the following codes in a Is-A hierarchy:

Code	Display	Definition
AW	Abatement of event after product withdrawn	Abatement of event after product withdrawn
BE	Event recurred after product reintroduced	Event recurred after product reintroduced
LI	Literature reports association of product with event	Literature reports association of product with event
IN	Event occurred after product introduced	Event occurred after product introduced
EX	Alternative explanations for the event available	Alternative explanations for the event available
PL	Effect observed when patient receives placebo	Effect observed when patient receives placebo
TC	Toxic levels of product documented in blood or body fluids	Toxic levels of product documented in blood or body fluids
DR	Dose response observed	Dose response observed
SE	Similar events in past for this patient	Similar events in past for this patient
OE	Occurrence of event was confirmed by objective evidence	Occurrence of event was confirmed by objective evidence
OT	Other	Other